The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Unsaturated Fatty Acids Drive Disintegrin and Metalloproteinase (ADAM)-dependent Cell Adhesion, Proliferation, and Migration by Modulating Membrane Fluidity
Abstract
The disintegrin-metalloproteinases ADAM10 and ADAM17 mediate the release of several cell signaling molecules and cell adhesion molecules such as vascular endothelial cadherin or L-selectin affecting endothelial permeability and leukocyte transmigration. Dysregulation of ADAM activity may contribute to the pathogenesis of vascular diseases, but the mechanisms underlying the control of ADAM functions are still incompletely understood. Atherosclerosis is characterized by lipid plaque formation and local accumulation of unsaturated free fatty acids (FFA). Here, we show that unsaturated FFA increase ADAM-mediated substrate cleavage. We demonstrate that these alterations are not due to genuine changes in enzyme activity, but correlate with changes in membrane fluidity as revealed by measurement of 1,6-diphenyl-1,3,5-hexatriene fluorescence anisotropy and fluorescence recovery after photobleaching analyses. ELISA and immunoblot experiments conducted with granulocytes, endothelial cells, and keratinocytes revealed rapid increase of ectodomain shedding of ADAM10 and ADAM17 substrates upon membrane fluidization. Large amounts of unsaturated FFA may be liberated from cholesteryl esters in LDL that is entrapped in atherosclerotic lesions. Incubation of cells with thus modified LDL resulted in rapid cleavage of ADAM substrates with corresponding functional consequences on cell proliferation, cell migration, and endothelial permeability, events of high significance in atherogenesis. We pro…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Precedents for such a tissue-specific proteolytic cleavage are the BACE1 substrates CHL1 and L1, which are mostly cleaved by BACE1 in the nervous system, but by ADAM proteases in non-neuronal cells [15, 37].”
From Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons (2016) · cites this paper as [37]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Deuss, M., Reiss, K., & Hartmann, D. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954686 · Cited by 98
Research works printed but not linked: 39
- Reiss, 2009, Semin. Cell Dev. Biol., 20, 126, 10.1016/j.semcdb.2008.11.002 · DOI
- Murphy, 2008, Nat. Rev. Cancer, 8, 929, 10.1038/nrc2459 · DOI · Paper page
- Pruessmeyer, 2009, Semin. Cell Dev. Biol., 20, 164, 10.1016/j.semcdb.2008.09.005 · DOI
- Li, 2006, Blood, 108, 2275, 10.1182/blood-2006-02-005827 · DOI
- Peschon, 1998, Science, 282, 1281, 10.1126/science.282.5392.1281 · DOI
- Maretzky, 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 9182, 10.1073/pnas.0500918102 · DOI
- Maretzky, 2008, J. Invest Dermatol., 128, 1737, 10.1038/sj.jid.5701242 · DOI
- Schulz, 2008, Circ. Res., 102, 1192, 10.1161/CIRCRESAHA.107.169805 · DOI
- Donners, 2010, Arterioscler. Thromb. Vasc. Biol., 30, 2188, 10.1161/ATVBAHA.110.213124 · DOI
- Kojro, 2001, Proc. Natl. Acad. Sci. U.S.A., 98, 5815, 10.1073/pnas.081612998 · DOI · Paper page
- Maretzky, 2005, Mol. Cell. Biol., 25, 9040, 10.1128/MCB.25.20.9040-9053.2005 · DOI
- Matthews, 2003, J. Biol. Chem., 278, 38829, 10.1074/jbc.M210584200 · DOI · Paper page
- Wilke, 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 13473, 10.1073/pnas.1001815107 · DOI
- Valeva, 2004, J. Biol. Chem., 279, 25143, 10.1074/jbc.M313913200 · DOI
- Gimpl, 2000, Eur. J. Biochem., 267, 2483, 10.1046/j.1432-1327.2000.01280.x · DOI
- Bhakdi, 2004, Circulation, 109, 1870, 10.1161/01.CIR.0000124228.08972.26 · DOI
- Ludwig, 2005, Comb. Chem. High Throughput Screen., 8, 161, 10.2174/1386207053258488 · DOI
- Haugwitz, 2006, Cell. Microbiol., 8, 1591, 10.1111/j.1462-5822.2006.00733.x · DOI · Paper page
- Merrill, 1987, Biochim. Biophys. Acta, 896, 89, 10.1016/0005-2736(87)90359-2 · DOI
- Nagy, 2007, Proc. Natl. Acad. Sci. U.S.A., 104, 7945, 10.1073/pnas.0702557104 · DOI
- Kenworthy, 2004, J. Cell Biol., 165, 735, 10.1083/jcb.200312170 · DOI
- Pucadyil, 2004, Biochemistry, 43, 15852, 10.1021/bi0480887 · DOI
- Le Gall, 2009, Mol. Biol. Cell, 20, 1785, 10.1091/mbc.e08-11-1135 · DOI
- Gómez-Gaviro, 2007, J. Immunol., 178, 8053, 10.4049/jimmunol.178.12.8053 · DOI
- Seifert, 1990, J. Exp. Med., 172, 547, 10.1084/jem.172.2.547 · DOI
- Bhakdi, 1995, J. Exp. Med., 182, 1959, 10.1084/jem.182.6.1959 · DOI
- Torzewski, 1998, Arterioscler. Thromb. Vasc. Biol., 18, 369, 10.1161/01.ATV.18.3.369 · DOI
- Edwards, 2008, Mol. Aspects Med., 29, 258, 10.1016/j.mam.2008.08.001 · DOI
- Murphy, 2009, Semin. Cell Dev. Biol., 20, 138, 10.1016/j.semcdb.2008.09.004 · DOI
- Le Gall, 2010, J. Cell Sci., 123, 3913, 10.1242/jcs.069997 · DOI
- Tellier, 2006, Exp. Cell Res., 312, 3969, 10.1016/j.yexcr.2006.08.027 · DOI
- Boden, 1997, Diabetes, 46, 3, 10.2337/diab.46.1.3 · DOI · Paper page
- Nogueira, 2008, Shock, 29, 342, 10.1097/SHK.0b013e31815abbc6 · DOI
- Suriyaphol, 2002, Circulation, 106, 2581, 10.1161/01.CIR.0000038366.11851.D0 · DOI
- Müller, 1995, Brain Res., 674, 133, 10.1016/0006-8993(94)01463-R · DOI
- Müller, 1998, Amyloid., 5, 10, 10.3109/13506129809007284 · DOI
- Carrié, 2009, Curr. Pharm. Des., 15, 4173, 10.2174/138161209789909764 · DOI
- Leskovjan, 2010, Anal. Chem., 82, 2711, 10.1021/ac1002728 · DOI
- Yang, 2010, J. Lipid Res., 51, 957, 10.1194/jlr.M002287 · DOI
Cited by
Sorted by citations
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144
Pigoni, M., Wanngren, J., Kuhn, P.-H., Munro, K. M., Gunnersen, J. M., Takeshima, H., Feederle, R., Voytyuk, I., De Strooper, B., Levasseur, M. D., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0134-z · Cited by 125
Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma
Lee, H. J., Chen, Z., Collard, M., Chen, F., Chen, J. G., Wu, M., Alani, R. M., & Cheng, J.-X. (2021) · BME Frontiers · doi:10.34133/2021/9860123 · Cited by 38
Metadata
- Authors
- Reiss, K., Cornelsen, I., Husmann, M., Gimpl, G., & Bhakdi, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 286
- Issue
- 30
- Pages
- 26931-26942
- ISSN
- 0021-9258
- Cited by
- 58
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review